| Code | 5052E | ||||||||||
| MA number | 68/0264/23-S | ||||||||||
| Product Form: | sol por 1x150 ml/150 mg (fľ.skl.jantár. + odm.pohár a striek.inj.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | amber glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.12.2023 |
| Validity: | 15.12.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Aripiprazol STADA 1 mg_ml perorálny roztok_11_2023.pdf
|
| SPC: |
SPC_Aripiprazol STADA 1 mg_ml perorálny roztok_11_2023.pdf
|
| Safety feature | Yes |
| Data update: | 21.12.2023 |
